User profiles for Daniel Ahn
Ahn DanielDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore … Verified email at jhu.edu Cited by 155 |
[HTML][HTML] Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma
…, Y Komatsu, K Masuda, D Ahn… - … England Journal of …, 2023 - Mass Medical Soc
Background Alterations in fibroblast growth factor receptor 2 (FGFR2) have emerged as
promising drug targets for intrahepatic cholangiocarcinoma, a rare cancer with a poor prognosis. …
promising drug targets for intrahepatic cholangiocarcinoma, a rare cancer with a poor prognosis. …
Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors
S Lu, D Ahn, G Johnson, S Cha - American Journal of …, 2003 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Diffusion tensor imaging (DTI) is an advanced MR technique
that describes the movement of water molecules by using two metrics, mean diffusivity (…
that describes the movement of water molecules by using two metrics, mean diffusivity (…
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results
…, BS Henick, CG Drake, BJ Solomon, DH Ahn… - Nature medicine, 2022 - nature.com
Checkpoint inhibitor (CPI) therapies provide limited benefit to patients with tumors of low
immune reactivity. T cell-inducing vaccines hold promise to exert long-lasting disease control in …
immune reactivity. T cell-inducing vaccines hold promise to exert long-lasting disease control in …
Biliary cancer: utility of next‐generation sequencing for clinical management
BACKGROUND Biliary tract cancers (BTCs) typically present at an advanced stage, and
systemic chemotherapy is often of limited benefit. METHODS Hybrid capture–based …
systemic chemotherapy is often of limited benefit. METHODS Hybrid capture–based …
Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial
…, M Iwasaki, P Masci, RK Ramanathan, DH Ahn… - JAMA …, 2019 - jamanetwork.com
Importance Administration of gemcitabine-cisplatin, the current standard therapy for advanced
biliary tract cancers, results in median progression-free survival and overall survival of 8.0 …
biliary tract cancers, results in median progression-free survival and overall survival of 8.0 …
Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index
S Lu, D Ahn, G Johnson, M Law, D Zagzag… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To determine whether diffusion-tensor magnetic resonance (MR) imaging metrics
of peritumoral edema can be used to differentiate intra- from extraaxial lesions, metastatic …
of peritumoral edema can be used to differentiate intra- from extraaxial lesions, metastatic …
Systemic therapy and sequencing options in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
Importance The treatment landscape for advanced hepatocellular carcinoma (HCC) has
recently changed and become relatively confusing. Head-to-head comparisons between most …
recently changed and become relatively confusing. Head-to-head comparisons between most …
Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study
TS Bekaii-Saab, FS Ou, DH Ahn, PM Boland… - The lancet …, 2019 - thelancet.com
Background Regorafenib confers an overall survival benefit in patients with refractory metastatic
colorectal cancer; however, the adverse event profile of regorafenib has limited its use. …
colorectal cancer; however, the adverse event profile of regorafenib has limited its use. …
Cholangiocarcinoma
DH Ahn, T Bekaii-Saab - Textbook of Gastrointestinal Oncology, 2019 - Springer
Biliary tract cancers (BTCs) are rare gastrointestinal malignancies that involve the liver and
biliary tract. Despite their being uncommon, there has been an increase in their incidence, …
biliary tract. Despite their being uncommon, there has been an increase in their incidence, …
The sword and the shield: The economics of targeted sanctions
DP Ahn, RD Ludema - European Economic Review, 2020 - Elsevier
How effective are “smart” sanctions in imposing costs on an adversary? We consider this
question in a model where a targeted regime may choose to “shield” strategically important …
question in a model where a targeted regime may choose to “shield” strategically important …